MDT Form 144: Insider Sale of 8,605 Vested Shares via Fidelity

Rhea-AI Filing Summary

Medtronic (MDT) Form 144 summary: The filing notifies an intended sale of 8,605 shares of Medtronic common stock held at Fidelity Brokerage Services, with an aggregate market value of $788,048.74. The shares were acquired on 08/01/2025 through restricted stock vesting from the issuer as compensation and the filer lists an approximate sale date of 09/03/2025 on the NYSE. The filing states there were no other securities sold by the same person in the past three months and includes the standard representation that the seller is not aware of undisclosed material adverse information.

Insights

Financial Analyst

TL;DR: Routine insider sale of vested restricted shares; size is negligible relative to total outstanding shares.

This Form 144 documents a planned sale of 8,605 vested shares valued at $788,048.74. Against the reported 1,282,685,882 shares outstanding, the transaction is immaterial to company capitalization and unlikely to affect market valuation. The acquisition via restricted stock vesting and disclosure through Form 144 aligns with standard insider liquidity events and compensation realization. No recent sales in the prior three months were reported, reducing the signal of accelerated insider selling.

Corporate Governance Expert

TL;DR: Proper procedural disclosure of a planned sale under Rule 144; no governance red flags in the filing.

The notice identifies the shares as compensation-based restricted stock that vested on 08/01/2025 and indicates sale via a broker on the NYSE. The filer includes the customary certification about lacking undisclosed material adverse information. There is no indication of noncompliance with disclosure requirements or of a trading plan referenced in the remarks. From a governance perspective, this is a standard, compliant disclosure of insider liquidity.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	8605	788048.74	1282685882	09/03/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/01/2025	Restricted Stock Vesting	Issuer			8605	08/01/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Medtronic's (MDT) Form 144 report?

The filing reports a proposed sale of 8,605 common shares valued at $788,048.74, acquired via restricted stock vesting on 08/01/2025.

When does the filer expect to sell the shares listed on the Form 144?

The Form 144 lists an approximate sale date of 09/03/2025 and indicates the sale will be executed through Fidelity Brokerage Services on the NYSE.

Were there other Medtronic (MDT) share sales by the same person in the past three months?

No. The filing explicitly states "Nothing to Report" for securities sold during the past three months by the reporting person.

How were the shares acquired according to the Form 144?

The shares were acquired on 08/01/2025 by restricted stock vesting from the issuer as compensation.

Does the filing indicate any undisclosed material adverse information?

The filer certifies they do not know of any material adverse information about the issuer that has not been publicly disclosed.